Sean M. Salmon serves as the Executive Vice President and President of the Cardiovascular Portfolio at Medtronic plc, a global leader in medical technology. In his current role, Salmon oversees a comprehensive portfolio that includes cardiac rhythm management, structural heart, and heart failure solutions. His leadership is pivotal in driving innovation and growth within Medtronic's cardiovascular business, which is crucial for the company's overall success. Before joining Medtronic, Salmon amassed a wealth of experience in the healthcare industry. He previously held the position of Group President at Zimmer Biomet, where he was responsible for managing the company's global knee, hip, and extremities businesses. Prior to Zimmer Biomet, Salmon spent over two decades at Johnson & Johnson, where he held various leadership roles, including Worldwide President of DePuy Synthes Spine and Worldwide President of DePuy Synthes Power Tools. His extensive background in medical devices and his strategic vision have been instrumental in his success at Medtronic. Salmon's achievements in the medical technology field are notable, particularly his contributions to the advancement of patient care through innovative solutions. Under his leadership at Medtronic, the Cardiovascular Portfolio has seen significant advancements in technology and market expansion. Salmon's strategic initiatives have not only enhanced Medtronic's competitive edge but also improved the quality of life for countless patients worldwide. His dedication to excellence and innovation continues to drive Medtronic's mission to alleviate pain, restore health, and extend life.